Gemcitabine plus oxaliplatin (GemOx) in advanced hepatocellular carcinoma (HCC): A multicenter study of over 200 patients.
N. Williet
No relevant relationships to disclose
A. Zaanan
No relevant relationships to disclose
M. Hebbar
No relevant relationships to disclose
V. Boige
No relevant relationships to disclose
L. Fartoux
No relevant relationships to disclose
T. Mansourbakht
No relevant relationships to disclose
O. Dubreuil
No relevant relationships to disclose
O. Rosmorduc
No relevant relationships to disclose
F. Bonnetain
No relevant relationships to disclose
J. Taïeb
No relevant relationships to disclose